Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6AA0

Crystal Structure of Toxoplasma gondii Prolyl tRNA Synthetase (TgPRS) in Apo Form

6AA0 の概要
エントリーDOI10.2210/pdb6aa0/pdb
分子名称Prolyl-tRNA synthetase (ProRS), GLYCEROL (2 entities in total)
機能のキーワードtoxoplasma gondii, proly trna synthetase, apo-form, inhibitor-bound structural comparison., translation
由来する生物種Toxoplasma gondii ME49
タンパク質・核酸の鎖数4
化学式量合計232854.16
構造登録者
Mishra, S.,Kumari, S.,Sharma, A.,Yogavel, M. (登録日: 2018-07-16, 公開日: 2019-10-23, 最終更新日: 2023-11-22)
主引用文献Mishra, S.,Malhotra, N.,Kumari, S.,Sato, M.,Kikuchi, H.,Yogavel, M.,Sharma, A.
Conformational heterogeneity in apo and drug-bound structures of Toxoplasma gondii prolyl-tRNA synthetase.
Acta Crystallogr.,Sect.F, 75:714-724, 2019
Cited by
PubMed Abstract: Prolyl-tRNA synthetase (PRS) is a member of the aminoacyl-tRNA synthetase family that drives protein translation in cells. The apicomplexan PRSs are validated targets of febrifugine (FF) and its halogenated derivative halofuginone (HF). PRSs are of great interest for drug development against Plasmodium falciparum and Toxoplasma gondii. In this study, structures of apo and FF-bound T. gondii (TgPRS) are revealed and the dynamic nature of the conformational changes that occur upon FF binding is unraveled. In addition, this study highlights significant conformational plasticity within two different crystal structures of apo PRSs but not within drug-bound PRSs. The apo PRSs exist in multi-conformational states and manifest pseudo-dimeric structures. In contrast, when FF is bound the PRS dimer adopts a highly symmetrical architecture. It is shown that TgPRS does not display extant fold switching, in contrast to P. falciparum PRS, despite having over 65% sequence identity. Finally, structure-comparison analyses suggest the utility of r.m.s.d. per residue (r.m.s.d.) as a robust tool to detect structural alterations even when the r.m.s.d. is low. Apo TgPRS reveals FF/HF-induced rigidity and this work has implications for drug-design studies that rely on the apo structures of target proteins.
PubMed: 31702585
DOI: 10.1107/S2053230X19014808
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (3.2 Å)
構造検証レポート
Validation report summary of 6aa0
検証レポート(詳細版)ダウンロードをダウンロード

248636

件を2026-02-04に公開中

PDB statisticsPDBj update infoContact PDBjnumon